期刊文献+

高糖对人脐静脉内皮细胞Toll样受体4表达的影响 被引量:1

Effect of high level of glucose and lipopolysaccharide on the expression of Toll-like receptor 4 in endothelial cells and its correlation with development of atherosclerosis
原文传递
导出
摘要 为探讨高糖和脂多糖(LPS)刺激下人脐静脉内皮细胞(HUVEC)TLR4的表达及高糖促进动脉粥样硬化与TLR4的关系,我们用RT-PCR和流式细胞术分别测定了高糖和LPS刺激下HUVECTLR4 mRNA和蛋白的表达;用ELISA测定高糖和LPS刺激下HUVECMCP-1的产生。研究结果表明,高糖上调HUVECTLR4 mRNA及其蛋白的表达,促进HU-VEC分泌MCP-1;高糖协同LPS上调HUVEC细胞TLR4蛋白的表达,使HUVEC分泌MCP-1进一步增加。研究发现,高糖促进动脉粥样硬化与TLR4有关;高糖可能协同感染因素促进动脉粥样硬化的发生。 To explore the effect of high level of glucose and lipopolysaccharide(LPS) on the expression of Toll-like receptor 4(TLR4) in human umbillical venous endothelial cells(HUVEC),the HUVEC were stimulated with high level of glucose and LPS,and then RT-PCR analysis and flow cytometry assay were used to measure the expression of TLR4 mRNA and protein on these cells.The concentration of MCP-1 was measured with ELISA. The results showed that high level of glucose up-regulated the gene and protein expression of TLR4 in HUVEC and promote the secretion of MCP-1 protein from these cells. High level of glucose co-effecting with high level of LPS.Also up-regulate the expression of TLR4 protein on these cells to induce the further secretion of MCP-1 protein. The results of our study suggest that the mechanism that high level of glucose accelerates the course of atherosclerosis may be related with the expression of TLR4,and possibly high level of glucose may co-effect with the infectious factors to induce the development of atherosclerosis.
出处 《现代免疫学》 CAS CSCD 北大核心 2010年第4期324-327,共4页 Current Immunology
关键词 高糖 TOLL样受体4 动脉粥样硬化 脂多糖 high glucose Toll-like receptor 4 atherosclerosis lipopolysaccharide
  • 相关文献

参考文献12

  • 1富宁.Toll样受体与病原相关分子模式[J].上海免疫学杂志,2001,21(4):195-198. 被引量:14
  • 2Michelsen KS, Doherty TM, Shah PK, et al. Tlr signaling : an emerging bridge from innate immunity to atherogenesis[J]. J Irnmunol, 2004, 173: 5901-5907. 被引量:1
  • 3Hansson GK. Inflammation, atherosclerosis, and coronary artery disease[J]. New Engl J Med, 2005, 352: 1685- 1695. 被引量:1
  • 4耿小勇,陈一文,秦明照.Toll样受体4在动脉粥样硬化中的作用研究进展[J].中国动脉硬化杂志,2008,16(1):78-80. 被引量:10
  • 5李震花,张涛,葛志明.高血糖加速动脉粥样硬化的分子生物学机制[J].中国动脉硬化杂志,2006,14(7):633-635. 被引量:13
  • 6Devaraj S, Dasu MR, Rockwood J, et al. Increased Toll- like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state[J]. J Clin Endocrinol Metab, 2007, 93:578-583. 被引量:1
  • 7Dasu MR, Devaraj S, Zhao L, et al. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation[J]. Diabetes, 2008, 57: 3090-3098. 被引量:1
  • 8Monick MM, Yarovinsky TO, Powers LS, et al. Respiratory syncytial virus up regulates TLR4 and sensitizes airway epithelial cells to endotoxin[J]. J Biol Chem, 2003, 278: 53035-53044. 被引量:1
  • 9Talreja J, Kabir MH, B Filla M, etal. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components[J]. Immunology, 2004, 113: 224-233. 被引量:1
  • 10Yumoto H, ChouHH, TakahashiY, etal. Sensitization of human aortic endothelial cells to lipopolysaeeharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion[J]. Infect Immun, 2005, 73: 8050-8059. 被引量:1

二级参考文献55

共引文献34

同被引文献12

  • 1孙丽萍,胡巢凤,周羽竝.人NOD2基因启动子的绿色荧光蛋白表达载体的构建[J].现代免疫学,2008,28(3):219-223. 被引量:3
  • 2胡巢凤.参与免疫及炎症反应调控的胞浆蛋白NODs[J].中国病理生理杂志,2004,20(7):1304-1308. 被引量:4
  • 3Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection[J]. J BiolChem, 2003, 278: 8869-8872. 被引量:1
  • 4Wang Y, Hasegawa M, ImamuraR, et al. NOD8, a novel Apaf-1/CED4-1ike protein is an inhibitor of ASC and caspase 1[J]. Int Immunol, 2004, 16: 777-786. 被引量:1
  • 5Liepinsh E, Barbals R. , Dahl E. , et al. The death domain fold of the ASC PYRIN domain, presenting a basis for PYRIN/PYRIN recognition. [J]. J Mol Biol, 2003, 332:1155 1163. 被引量:1
  • 6Wagner RN, Proell M, Kufer TA, et al. Evaluation of Nod-like receptor (NLR) effector domain interactions [J]. PLoSONE, 2009, 4: 1371-1381. 被引量:1
  • 7Harris S, Levine A. The p53 pathway: positive and negative feedback loops [J]. Oncogene, 2005, 24: 2899 2908. 被引量:1
  • 8El-Deiry W, Kern S, Pietenpol J, et al. Definiton of a consensus binding site for p53 [J]. Nat Genet, 1992, 1: 45-49. 被引量:1
  • 9Bourdon J, Deguin-Chambon V, Lelong J, etal. Further characterization of the p53 responsive element-identification of new candidate genes for transactivation by p53 [J]. Onco gene, 1997, 14:85-94. 被引量:1
  • 10Wang L, Wu Q, Qiu P, et al. Analyses of p53 target genes in the human genome by bioinformatic and microarray appros chea [J]. J Biol Chem, 2001, 276: 43604-43610. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部